CN Patent

CN107250113B — 囊性纤维化跨膜传导调节蛋白的调节剂的共晶

Assigned to Vertex Pharmaceuticals Inc · Expires 2019-03-29 · 7y expired

What this patent protects

本公开涉及包含N‑[2,4‑双(1,1‑二甲基乙基)‑5‑羟基苯基]‑1,4‑二氢‑4‑氧代喹啉‑3‑甲酰胺(化合物1)和共形成物的共晶及其制备方法。本公开还涉及包括共晶形式的药物组合物和利用其治疗的方法和试剂盒。

USPTO Abstract

本公开涉及包含N‑[2,4‑双(1,1‑二甲基乙基)‑5‑羟基苯基]‑1,4‑二氢‑4‑氧代喹啉‑3‑甲酰胺(化合物1)和共形成物的共晶及其制备方法。本公开还涉及包括共晶形式的药物组合物和利用其治疗的方法和试剂盒。

Drugs covered by this patent

Patent Metadata

Patent number
CN107250113B
Jurisdiction
CN
Classification
—
Expires
2019-03-29
Drug substance claim
No
Drug product claim
No
Assignee
Vertex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.